Patent · US Active

Dual release oral tablet compositions of dexlansoprazole

US8563034B2 · kind B2 · utility

0Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 5, 2011
Grant dateOct 22, 2013
Priority date
Expiry dateMay 5, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.